HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luisa Guidi Selected Research

Thyroxine (Levothyroxine)

1/2021Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luisa Guidi Research Topics

Disease

24Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2022 - 06/2009
16Ulcerative Colitis
02/2022 - 06/2009
12Crohn Disease (Crohn's Disease)
07/2023 - 08/2008
6Neoplasms (Cancer)
11/2020 - 06/2009
4Necrosis
07/2023 - 11/2013
4Infections
03/2013 - 06/2009
3Fistula
07/2023 - 01/2011
3Inflammation (Inflammations)
10/2020 - 11/2014
2Rheumatoid Arthritis
01/2018 - 01/2011
2Psoriatic Arthritis
01/2018 - 01/2011
2Latent Tuberculosis
03/2013 - 06/2009
2Hepatitis B
03/2013 - 06/2009
1Intestinal Failure
11/2022
1Short Bowel Syndrome
11/2022
1Frailty
01/2021
1Cough
01/2020
1COVID-19
01/2020
1Fever (Fevers)
01/2020
1Liver Diseases (Liver Disease)
07/2018
1Arthritis (Polyarthritis)
01/2018
1Opportunistic Infections (Opportunistic Infection)
08/2016
1Virus Diseases (Viral Diseases)
08/2016
1Pulmonary Embolism
03/2014
1Cytomegalovirus Infections (Inclusion Disease)
03/2014
1Latent Infection
03/2013
1Tuberculosis (Tuberculoses)
03/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2011
1Ankylosing Spondylitis
01/2011
1Hereditary Hemorrhagic Telangiectasia
08/2010

Drug/Important Bio-Agent (IBA)

11Infliximab (Remicade)FDA Link
02/2022 - 08/2008
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2019 - 06/2009
4Adalimumab (Humira)FDA Link
09/2013 - 01/2011
3Immunologic Factors (Immunomodulators)IBA
11/2020 - 08/2016
3Tumor Necrosis Factor InhibitorsIBA
01/2018 - 01/2011
3SteroidsIBA
08/2014 - 04/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2014 - 11/2011
2Biosimilar PharmaceuticalsIBA
02/2022 - 01/2017
2CT-P13IBA
02/2022 - 01/2017
2vedolizumabIBA
12/2019 - 11/2019
2Therapeutic UsesIBA
07/2018 - 11/2014
2Azathioprine (Imuran)FDA LinkGeneric
08/2014 - 12/2013
1Glucagon (Glukagon)FDA Link
11/2022
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2021
1Growth Factor ReceptorsIBA
10/2020
1Cetuximab (Erbitux)FDA Link
10/2020
1Monoclonal AntibodiesIBA
10/2020
1MagnesiumIBA
10/2020
1Phosphodiesterase 4 InhibitorsIBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2018
1Immunoglobulin A (IgA)IBA
01/2018
1Ustekinumab (CNTO 1275)FDA Link
01/2018
1Antirheumatic Agents (DMARD)IBA
01/2018
12-mercaptopurineIBA
01/2018
1golimumabFDA Link
01/2016
1Hormones (Hormone)IBA
12/2015
1Estrogens (Estrogen)FDA Link
12/2015
1Estrogen ReceptorsIBA
12/2015
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
11/2014
1Influenza Vaccines (Influenza Vaccine)FDA Link
03/2013
1Tuberculin (PPD)IBA
03/2013
1GoldIBA
03/2013
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
10/2008
1Phenobarbital (Luminal)FDA Link
10/2008
1Certolizumab PegolFDA Link
08/2008

Therapy/Procedure

18Therapeutics
07/2023 - 06/2009
4Biological Therapy
02/2021 - 01/2011
2Colectomy
08/2014 - 01/2013
1Hand Hygiene
01/2020
1Precision Medicine
03/2019
1Anesthesia
02/2015
1Contraindications
01/2013
1Blood Component Removal (Apheresis)
01/2012